Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-01-29 01:11 | 2021-01-26 | GIM | Saba Capital Income & Opportunities Fund II | Saba Capital Management, L.P. | 10% owner | Other | BUY | $5.63 | 924,941 | $5,207,140 | 23,526,106 | +4.1% |
| 2021-01-29 04:16 | 2021-01-27 | PDO | PIMCO Dynamic Income Opportunities Fund | Roman Emmanuel | Other | Other | BUY | $20.00 | 100,000 | $2,000,000 | 100,000 | +100.0% |
| 2021-01-29 04:07 | 2021-01-27 | PDO | PIMCO Dynamic Income Opportunities Fund | IVASCYN DANIEL J | Other | Other | BUY | $20.00 | 250,000 | $5,000,000 | 250,000 | +100.0% |
| 2021-01-29 01:39 | 2021-01-26 | LMACA | N/A | YANG GEOFFREY Y | Director | Other | BUY | $10.00 | 300,000 | $3,000,000 | 300,000 | +100.0% |
| 2021-01-29 01:39 | 2021-01-26 | LMACA | N/A | ROSENTHALER ALBERT E | Officer - Chief Corp. Dev. Officer | Other | BUY | $10.00 | 100,000 | $1,000,000 | 100,000 | +100.0% |
| 2021-01-29 01:39 | 2021-01-26 | LMACA | N/A | MAFFEI GREGORY B | Director, Officer - President/CEO | Other | BUY | $10.00 | 740,251 | $7,402,510 | 740,251 | +100.0% |
| 2021-01-28 21:43 | 2021-01-26 | ARMP | Armata Pharmaceuticals Inc. | Innoviva, Inc. | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $3.25 | 1,867,912 | $6,070,714 | 1,867,912 | +100.0% |
| 2021-01-28 00:59 | 2021-01-25 | DFH | Dream Finders Homes, Inc. | BOSTON OMAHA Corp | 10% owner | Operative Builders | BUY | $13.00 | 120,000 | $1,560,000 | 4,801,099 | +2.6% |
| 2021-01-28 03:27 | 2021-01-01 | N-A | N/A | Partners Group Private Equity II, LLC | Other | Other | BUY | $6.79 | 1,473,362 | $10,000,000 | 12,302,568 | +13.6% |
| 2021-01-27 20:18 | 2021-01-25 | ONCS | N/A | China Grand Pharmaceutical & Healthcare Holdings Ltd | 10% owner | Other | BUY | $5.45 | 4,067,037 | $22,165,352 | 3,077,639 | +100.0% |
| 2021-01-28 00:40 | 2021-01-25 | INTC | INTEL CORP | SWAN ROBERT HOLMES | Director, Officer - CEO | Semiconductors & Related Devices | BUY | $55.57 | 27,244 | $1,514,004 | 345,318 | +8.6% |
| 2021-01-28 01:43 | 2021-01-25 | ATHA | LeonaBio, Inc. | PERCEPTIVE ADVISORS LLC | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $22.50 | 311,111 | $6,999,998 | 3,425,916 | +10.0% |
| 2021-01-27 20:58 | 2021-01-26 | FRG | N/A | Vintage Capital Management LLC | 10% owner | Other | BUY | $34.95 | 757,000 | $26,457,150 | 6,394,628 | +13.4% |
| 2021-01-28 01:49 | 2021-01-25 | GRBK | Green Brick Partners, Inc. | EINHORN DAVID | Director, 10% owner | Operative Builders | BUY | $20.55 | 850,000 | $17,467,500 | 850,000 | +100.0% |
| 2021-01-26 21:39 | 2021-01-25 | N/A | N/A | MASSACHUSETTS MUTUAL LIFE INSURANCE CO | 10% owner | Other | BUY | $21.58 | 807,166 | $17,418,638 | 133,680 | +100.0% |
| 2021-01-27 00:27 | 2021-01-25 | N/A | N/A | Alberta Investment Management Corp | 10% owner | Other | BUY | $21.58 | 56,974 | $1,229,500 | 1,923,400 | +3.1% |
| 2021-01-27 00:57 | 2021-01-22 | HY | HYSTER-YALE, INC. | RANKIN CORBIN | Other | Industrial Trucks, Tractors, Trailors & Stackers | BUY | $55.50 | 22,056 | $1,224,108 | 8,228 | +100.0% |
| 2021-01-27 00:55 | 2021-01-22 | HY | HYSTER-YALE, INC. | RANKIN THOMAS T | Other | Industrial Trucks, Tractors, Trailors & Stackers | BUY | $55.50 | 22,056 | $1,224,108 | 8,228 | +100.0% |
| 2021-01-27 00:50 | 2021-01-22 | HY | HYSTER-YALE, INC. | RANKIN CHLOE O | Other | Industrial Trucks, Tractors, Trailors & Stackers | BUY | $55.50 | 22,054 | $1,223,997 | 8,228 | +100.0% |
| 2021-01-27 00:49 | 2021-01-22 | HY | HYSTER-YALE, INC. | RANKIN CLAIBORNE R | Director, Other | Industrial Trucks, Tractors, Trailors & Stackers | BUY | $55.50 | 22,054 | $1,223,997 | 8,227 | +100.0% |
| 2021-01-27 03:52 | 2021-01-06 | UONE | URBAN ONE, INC. | SEMLER ERIC | 10% owner | Radio Broadcasting Stations | BUY | $4.79 | 615,523 | $2,948,663 | 2,221,197 | +38.3% |
| 2021-01-26 02:51 | 2021-01-21 | MRUS | Merus N.V. | BVF PARTNERS L P/IL | 10% owner | Pharmaceutical Preparations | BUY | $24.75 | 844,680 | $20,905,830 | 426,206 | +100.0% |
| 2021-01-23 00:34 | 2021-01-20 | N/A | Morgan Stanley Direct Lending Fund | MS Credit Partners Holdings Inc. | 10% owner | Other | BUY | $20.27 | 195,856 | $3,970,004 | 2,321,350 | +9.2% |
| 2021-01-23 00:26 | 2021-01-22 | PRVL | N/A | Tyto Acquisition Corp | 10% owner | Other | BUY | $22.50 | 34,284,789 | $771,407,753 | 100 | +100.0% |
| 2021-01-22 20:20 | 2021-01-20 | GIM | Saba Capital Income & Opportunities Fund II | Saba Capital Management, L.P. | 10% owner | Other | BUY | $5.60 | 419,420 | $2,348,752 | 22,440,422 | +1.9% |
| 2021-01-23 00:28 | 2021-01-20 | OCX | Insight Molecular Diagnostics Inc. | BROADWOOD PARTNERS, L.P. | 10% owner | In Vitro & In Vivo Diagnostic Substances | BUY | $3.42 | 1,460,280 | $4,999,999 | 16,176,484 | +9.9% |
| 2021-01-22 03:23 | 2021-01-21 | CMCT | Creative Media & Community Trust Corp | RESSLER RICHARD S | Director, 10% owner | Real Estate Investment Trusts | BUY | $25.00 | 96,740 | $2,418,500 | 298,472 | +48.0% |
| 2021-01-22 03:22 | 2021-01-21 | CMCT | Creative Media & Community Trust Corp | CIM Capital, LLC | Other | Real Estate Investment Trusts | BUY | $25.00 | 96,740 | $2,418,500 | 287,199 | +50.8% |
| 2021-01-22 03:24 | 2021-01-21 | CMCT | Creative Media & Community Trust Corp | Kuba Shaul | Director, 10% owner | Real Estate Investment Trusts | BUY | $25.00 | 96,740 | $2,418,500 | 298,472 | +48.0% |
| 2021-01-22 03:24 | 2021-01-21 | CMCT | Creative Media & Community Trust Corp | Shemesh Avraham | Director, 10% owner | Real Estate Investment Trusts | BUY | $25.00 | 96,740 | $2,418,500 | 298,472 | +48.0% |
| 2021-01-22 01:24 | 2021-01-19 | ALDX | Aldeyra Therapeutics Inc. | PERCEPTIVE ADVISORS LLC | 10% owner | Pharmaceutical Preparations | BUY | $9.50 | 1,368,421 | $13,000,000 | 8,703,879 | +18.7% |
| 2021-01-20 19:34 | 2021-01-15 | CRAWA | Crawford United Corp. | CRAWFORD EDWARD F | 10% owner | Industrial Instruments For Measurement, Display, and Control | BUY | $17.65 | 60,000 | $1,059,000 | 282 | +100.0% |
| 2021-01-21 00:23 | 2021-01-20 | TBA | N/A | Thoma Bravo Advantage Sponsor, LLC | 10% owner | Other | BUY | $2,000,000.00 | 200,000 | $400,000,000,000 | 2,400,000 | +9.1% |
| 2021-01-20 16:42 | 2021-01-15 | GIM | Saba Capital Income & Opportunities Fund II | Saba Capital Management, L.P. | 10% owner | Other | BUY | $5.56 | 369,761 | $2,057,535 | 22,021,002 | +1.7% |
| 2021-01-21 04:25 | 2021-01-15 | AFRM | Affirm Holdings, Inc. | Founders Fund V Management, LLC | 10% owner | Personal Credit Institutions | BUY | $49.00 | 75,000 | $3,675,000 | 75,000 | +100.0% |
| 2021-01-16 00:19 | 2021-01-13 | AFRM | Affirm Holdings, Inc. | Rabois Keith | Director | Personal Credit Institutions | BUY | $49.00 | 75,000 | $3,675,000 | 75,000 | +100.0% |
| 2021-01-16 00:19 | 2021-01-13 | AFRM | Affirm Holdings, Inc. | Philips Jeremy | Director | Personal Credit Institutions | BUY | $49.00 | 75,000 | $3,675,000 | 5,699 | +100.0% |
| 2021-01-15 23:04 | 2021-01-14 | GIM | Saba Capital Income & Opportunities Fund II | Saba Capital Management, L.P. | 10% owner | Other | BUY | $5.59 | 275,000 | $1,537,250 | 21,651,241 | +1.3% |
| 2021-01-16 01:31 | 2021-01-13 | AFRM | Affirm Holdings, Inc. | Khosla Ventures IV, L.P. | 10% owner | Personal Credit Institutions | BUY | $49.00 | 75,000 | $3,675,000 | 422,011 | +21.6% |
| 2021-01-14 21:32 | 2021-01-14 | BCYP | SAB Biotherapeutics, Inc. | Katz Ilan | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $10.00 | 417,200 | $4,172,000 | 3,047,825 | +15.9% |
| 2021-01-14 21:30 | 2021-01-14 | BCYP | SAB Biotherapeutics, Inc. | Big Cypress Holdings LLC | Director, Officer, 10% owner - CEO and CFO | Biological Products, (No Diagnostic Substances) | BUY | $10.00 | 417,200 | $4,172,000 | 3,047,825 | +15.9% |
| 2021-01-14 14:11 | 2021-01-12 | MCADU | Better Therapeutics Inc. | Mountain Crest Capital LLC | 10% owner | Services-Health Services | BUY | $10.00 | 135,000 | $1,350,000 | 1,566,500 | +9.4% |
| 2021-01-14 20:18 | 2021-01-12 | SVFA | N/A | Govi Navneet | Director, Officer - Chief Financial Officer | Other | BUY | $10.00 | 150,000 | $1,500,000 | 150,000 | +100.0% |
| 2021-01-15 00:22 | 2021-01-12 | EPWR | N/A | Jefferies Financial Group Inc. | 10% owner | Other | BUY | $10.00 | 250,000 | $2,500,000 | 250,000 | +100.0% |
| 2021-01-14 14:07 | 2021-01-12 | MCADU | Better Therapeutics Inc. | Liu Dong | Director, Officer, 10% owner - Chief Financial Officer | Services-Health Services | BUY | $10.00 | 135,000 | $1,350,000 | 1,566,500 | +9.4% |
| 2021-01-14 14:09 | 2021-01-12 | MCADU | Better Therapeutics Inc. | Liu Suying | Director, Officer, 10% owner - Chief Executive Officer | Services-Health Services | BUY | $10.00 | 135,000 | $1,350,000 | 1,566,500 | +9.4% |
| 2021-01-15 01:54 | 2021-01-12 | CGEM | Cullinan Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $21.00 | 300,000 | $6,300,000 | 7,913,887 | +3.9% |
| 2021-01-15 01:30 | 2021-01-12 | CGEM | Cullinan Therapeutics, Inc. | Jovan-Embiricos Morana | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $21.00 | 200,000 | $4,200,000 | 104,762 | +100.0% |
| 2021-01-14 21:33 | 2021-01-14 | BCYP | SAB Biotherapeutics, Inc. | Reich Samuel J | Director, Officer, 10% owner - CEO and CFO | Biological Products, (No Diagnostic Substances) | BUY | $10.00 | 417,200 | $4,172,000 | 3,047,825 | +15.9% |
| 2021-01-15 01:51 | 2021-01-12 | CGEM | Cullinan Therapeutics, Inc. | GADICKE ANSBERT | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $21.00 | 300,000 | $6,300,000 | 7,913,887 | +3.9% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.